Executive Cost & Value Dashboard
Review the value summary, TDM ROI, budget impact, ICER, sensitivity, and HTA readiness together.
Value Evidence Summary
Bring the economic, clinical, budget, and affordability evidence into one decision view.
TDM vs Empirical ROI
Compare monitoring investment with toxicity, failure, and length-of-stay offsets.
Dosing Cost
Review treatment and administration cost components.
Regimen Value Matrix
Compare regimen cost, effectiveness, safety, and overall value.
Budget Impact Analysis
Project annual population, cost, savings, and return over the selected horizon.
Cost-Effectiveness · ICER · Net Monetary Benefit
Assess incremental cost, QALY gain, ICER, and net monetary benefit.
Sensitivity / Tornado
Identify the assumptions that most influence savings and decision confidence.
Scenario Analysis
Compare value outcomes across plausible adoption and cost scenarios.
HTA Dossier
Review evidence readiness for health technology assessment and formulary review.
Formulary Brief & Full Report
Prepare review-ready findings and an executive value report.
Patient Affordability
Assess out-of-pocket burden against patient income.
Value-Based Pricing
Estimate pricing headroom from the selected value threshold.
